Showing results (1-10 of 10) with videos related to
Sort By:
Pageof 1
Cancer Journal (Sudbury, Mass.)|September 26, 2012
Brentuximab vedotin and crizotinib in anaplastic large-cell lymphomaKelley V Foyil, Nancy L BartlettImmunotherapy|April 6, 2011
Brentuximab vedotin for the treatment of CD30+ lymphomasKelley V Foyil, Nancy L BartlettCurrent Hematologic Malignancy Reports|May 7, 2010
Anti-CD30 Antibodies for Hodgkin lymphomaKelley V Foyil, Nancy L BartlettJournal of Endourology|January 24, 2006
Alteration in irrigant flow and deflection of flexible ureteroscopes with nitinol basketsCaroline D Ames, Juan M Perrone, Kyle J Weld, et al.Applied Immunohistochemistry & Molecular Morphology : AIMM|June 13, 2015
Expression of TIA1 and PAX5 in Classical Hodgkin Lymphoma at Initial Diagnosis May Predict Clinical OutcomeTuDung T Nguyen, John L Frater, Jonathan Klein, et al.The Journal of Thoracic and Cardiovascular Surgery|April 1, 2008
Pulmonary vein isolation and the Cox maze procedure only partially denervate the atriumShelly C Lall, Kelley V Foyil, Shun-ichiro Sakamoto, et al.Therapeutic Advances in Hematology|February 4, 2014
Rituximab is associated with improved survival in Burkitt lymphoma: a retrospective analysis from two US academic medical centersTanya M Wildes, Laura Farrington, Cecilia Yeung, et al.Urology|July 5, 2005
Laparoscopic renal parenchymal hypothermia with novel ice-slush deployment mechanismCaroline D Ames, Ramakrishna Venkatesh, Kyle J Weld, et al.Journal of the American College of Surgeons|March 1, 2008
Longterm changes in creatinine clearance after laparoscopic renal surgeryKelley V Foyil, Caroline D Ames, Genoa G Ferguson, et al.American Journal of Clinical Pathology|February 12, 2014
CD163 immunohistochemistry is superior to CD68 in predicting outcome in classical Hodgkin lymphomaJonathan L Klein, TuDung T Nguyen, Gabriel A Bien-Willner, et al.Pageof 1